weight regain after stopping semaglutide trial maintenance discontinuation of GLP-1 therapies Rebound or Retention: A Meta-Analysis
Description
Amturnide (aliskiren
Blood tests may help rule out other conditions
Still, a large-scale French study did find a potential link between GLP-1 use and thyroid cancer, especially in patients who used the drug for more than a year
This occurs primarily through its influence on appetite regulation: Increased Satiety: By activating GLP-1 receptors in the brain, particularly in areas involved in appetite control, semaglutide enhances feelings of fullness and satisfaction after eating
Pen injectors allow manual dose selection and activation, offering flexibility for adjustable dosing
